Thromboembolism: Clinical Trials

167 trials for Thromboembolism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

85 completed, 25 recruiting, 21 unknown, 10 not yet recruiting. 167 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable167Completed 85, Recruiting 25, Unknown 21, Not yet recruiting 10, Terminated 9, Active not recruiting 7, Withdrawn 5, Suspended 3, Enrolling by invitation 2

Follow Thromboembolism: new trials by email Literature Review of Thromboembolism trials Research Report on Thromboembolism

Trials (filtered) newest first · largest first

All 167 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The MInimizing RIsk of CLotting Events Trial
VTE Risk Assessment CDS Tool - Venous Thromboembolism (VTE)
Not applicableNot yet recruitingNational Heart, Lung, and Blood Institute (NHLBI)650002026-11-012026-11-12
Comparison of DOACs and LMWH for Thromboprophylaxis After Total Knee Arthroplasty
Apixaban, Rivaroxaban, Enoxaparin (LMWH) - Total Knee Arthroplasty, Venous Thromboembolism
Not applicableRecruitingMilitary Hospital of Tunis1382026-09-152026-10-16
Decision Aid for Anticoagulation Duration After Unprovoked Venous Thromboembolism
DECIDE-VTE Patient Decision Aid - Venous Thromboembolism (VTE), Deep Vein Thrombosis (DVT)
Not applicableNot yet recruitingMcGill University Health Centre/Research Institute of the McGill University Health Centre8502026-09-012026-06-24
Smart Technology Facilitated Patient-centered Care for Patients With Pulmonary Thromboembolism
mobile venous thromboembolism application (mVTEA) - Venous Thromboembolism, Pulmonary Thromboembolisms
Not applicableRecruitingNavy General Hospital, Beijing29722026-08-202026-09-09
The OAT Trail: The Obesity Anti-Coagulation Thromboprophylaxis Trial.
Anti-Xa Activity Monitoring, Tinzaparin (Leo), enoxaparin - Bariatric Surgery, Anti-Xa Activity
Not applicableNot yet recruitingUniversity College Dublin1802026-08-012026-05-18
Pulmonary Embolism in Patients With Acute Heart Failure (PEHF Study)
Systematic screening for pulmonary embolism in all patients using a guideline-recommended diagnostic algorithm - Acute Heart Failure (AHF), Pulmonary Embolism (Diagnosis)
Not applicableRecruitingUniversity Hospital, Angers7402026-07-152026-07-17
Delivery and Implementation of a Randomised Crossover Trial on Thrombosis
Patients in hospitals allocated to this arm will receive aspirin as their routine thromboprophylaxis after surgery., Low molecular weight heparin (LMWH) - Hip Fractures, Venous Thromboembolism (VTE)
Not applicableRecruitingQueen Mary University of London211942026-07-012026-09-23
Stepwise vs Standard Anticoagulation for AF Patients Undergoing CIED Implantation (STEP-AF)
Stepwise Anticoagulation Regimen, Standard Anticoagulation Regimen - Non-valvular Atrial Fibrillation (NVAF), Thromboembolism
Not applicableNot yet recruitingFu Wai Hospital, Beijing, China4242026-05-262026-06-01
Intermediate Versus Standard Dose Enoxaparin to Prevent Venous Thromboembolism in Severe Trauma Patients: a Multicenter Double Blind Randomised Controlled Trial
Enoxaparin standard dose, Enoxaparin intermediate dose - Severe Trauma Patient, Venous Thromboembolism
Not applicableNot yet recruitingUniversity Hospital, Grenoble5402026-04-012026-04-29
Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
MSK-ACCESS, ctDNA/VTE Risk Score: - Venous Thromboembolism, Deep Venous Thrombosis
Not applicableRecruitingMemorial Sloan Kettering Cancer Center2592026-01-302026-11-09
Early Exercise-Based Rehabilitation in Patients Hospitalized for Acute Pulmonary Embolism
Exercise-based rehabilitation program - Venous Thromboembolism (VTE), Exercise Therapy
Not applicableRecruitingInsel Gruppe AG, University Hospital Bern1602025-12-172026-06-12
Rivaroxaban vs Enoxaparin After Cesarean Section: Laboratory Thromboprophylaxis Outcomes
Rivaroxaban, Enoxaparin 40 mg - Postpartum Period, Cesarean Section Surgery
Not applicableRecruitingWolfson Medical Center622025-12-012026-09-15
Shared Decision-making Process for Unprovoked vEnous THromboEmbolism Management. (ETHER )
Usual Care Group, shared decision-making process - Venous Thromboembolism
Not applicableRecruitingUniversity Hospital, Brest24002025-10-302025-11-28
Informative Video Before LMWH Postpartum - Randomized Controlled Trial
Informative Video on LMWH, Standard Verbal Explanation - Venous Thromboembolism (VTE), Postpartum Care
Not applicableNot yet recruitingWolfson Medical Center1602025-10-152025-09-11
Implementing VTE Prevention in Ambulatory Cancer Care
Clinical program - Venous Thromboembolism, Neoplasms
Not applicableEnrolling by invitationUniversity of Vermont252025-10-012025-12-18
Impact of Remote Care in Patients Diagnosed With Thromboembolic Disease of Low Risk
4G tablet - Thromboembolic Disease
Not applicableRecruitingCentre Hospitalier Eure-Seine502025-09-012025-09-15
Discontinuation of Anticoagulation With Intensive Rhythm Monitoring in Post-ablation Patients With Atrial Fibrillation
NOAC discontinuation, NOAC continuation, Smartwatch single-lead ECG monitoring - Atrial Fibrillation (AF)
Not applicableRecruitingBeijing Anzhen Hospital41002025-08-052026-03-04
CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism
The multifaceted interventions, Routine VTE prophylaxis - Venous Thromboembolic Disease, Pulmonary Embolism
Not applicableRecruitingChina-Japan Friendship Hospital58002025-08-012025-09-17
The Effect of a VTE Prevention Care Bundle in Total Hip Arthroplasty Patients
VTE Prevention Care Bundle, Standard Routine Care - Venous Thromboembolism, Total Hip Arthroplasty (THA)
Not applicableActive not recruitingMurat Erten1102025-06-172026-07-14
The Protrieve PROTECTOR Study
Percutaneous mechanical thrombectomy (PMT) - Venous Thromboembolism, Deep Venous Thrombosis
Not applicableCompletedInari Medical662025-03-052026-10-05

Showing 20 of 167. Sign in to see all of them.

Narrower conditions

Venous Thromboembolism (110)  ·  Pulmonary Embolism (35)  ·  Venous Thrombosis (33)  ·  Thrombosis (15)  ·  Atrial Fibrillation (14)  ·  Stroke (13)  ·  Intracranial Embolism (7)  ·  Intracranial Thrombosis (7)  ·  Hemorrhage (6)  ·  Neoplasms (6)  ·  Cardiovascular Diseases (5)  ·  Wounds and Injuries (5)  ·  COVID-19 (4)  ·  Embolism (4)

Broader conditions

Embolism and Thrombosis (165)  ·  Vascular Diseases (163)  ·  Cardiovascular Diseases (162)  ·  Pathological Conditions, Signs and Symptoms (47)  ·  Respiratory Tract Diseases (42)  ·  Lung Diseases (40)  ·  Pathologic Processes (40)  ·  Nervous System Diseases (36)  ·  Embolism (33)  ·  Central Nervous System Diseases (31)  ·  Brain Diseases (29)  ·  Thrombosis (29)  ·  Cerebrovascular Disorders (27)  ·  Heart Diseases (20)

Interventions

Enoxaparin (13)  ·  Rivaroxaban (12)  ·  Warfarin (8)  ·  apixaban (7)  ·  Heparin, Low-Molecular-Weight (6)  ·  Aspirin (4)  ·  Dalteparin (4)  ·  Heparin (4)  ·  Blood Specimen Collection (3)  ·  Dabigatran (3)  ·  Fondaparinux (3)  ·  edoxaban (3)  ·  Educational Status (2)  ·  Endarterectomy, Carotid (2)  ·  Standard of Care (2)

Sponsors

Brigham and Women's Hospital (4)  ·  Hospices Civils de Lyon (4)  ·  Insel Gruppe AG, University Hospital Bern (4)  ·  University Hospital, Brest (4)  ·  Inari Medical (3)  ·  Johns Hopkins University (3)  ·  Karolinska University Hospital (3)  ·  Navy General Hospital, Beijing (3)  ·  Vanderbilt University Medical Center (3)  ·  Assistance Publique Hopitaux De Marseille (2)  ·  BiO2 Medical (2)  ·  Imperial College London (2)  ·  M.D. Anderson Cancer Center (2)  ·  Memorial Sloan Kettering Cancer Center (2)  ·  National Heart, Lung, and Blood Institute (NHLBI) (2)

Countries

United States (57)  ·  France (23)  ·  China (14)  ·  Canada (10)  ·  United Kingdom (10)  ·  Switzerland (8)  ·  Australia (6)  ·  Israel (5)  ·  Italy (4)  ·  Russia (4)  ·  Turkey (Türkiye) (4)  ·  Germany (3)  ·  Netherlands (3)  ·  Sweden (3)  ·  Belgium (2)

Top investigators

Alok Kapoor, MD (2)  ·  Amihai Rottenstreich, MD (2)  ·  Elliott R Haut, MD PhD (2)  ·  Paul W Ackermann, MD, PhD (2)  ·  Victor Tapson, MD (2)  ·  Abdulhameed Gasim, MD (1)  ·  Adam Cuker, MD (1)  ·  Alex Spyropoulos, MD (1)  ·  Allison P Wheeler, MD (1)  ·  Alun Davies (1)  ·  Alun H Davies (1)  ·  Alvar Agusti, MD, PhD (1)

Results publications

PMID 34597414, PMID 33779986, PMID 11867132, PMID 11982463, PMID 12131409, PMID 14987333, PMID 15132746, PMID 15234649, PMID 15319720, PMID 15811953, PMID 15842354, PMID 16009794, PMID 16307934, PMID 16456434, PMID 17215729, PMID 18086925, PMID 19036065, PMID 19458109, PMID 19875061, PMID 19878532, PMID 20332509, PMID 20386359, PMID 20622663, PMID 20626619, PMID 21900088, PMID 22315257, PMID 22315263, PMID 22315264, PMID 23013426, PMID 23303884, PMID 2352304, PMID 23780517, PMID 24141714, PMID 24195920, PMID 25922463, PMID 25940537, PMID 26095467, PMID 26201391, PMID 26672686, PMID 26699594, PMID 26817957, PMID 26868660, PMID 27126650, PMID 27349472, PMID 27440463, PMID 27605222, PMID 27764880, PMID 27900179, PMID 28367699, PMID 28668970

NIH funding

2025 (2), 2017 (1), 2019 (1), K23HL112908 (1), K23HL132054 (1), P30CA016672 (1), P30CA138313 (1), R01HL164482 (1), U01HL063942 (1)